Brought to you by 
Guidant buys BioStent
Apr 2003
Executive Summary
Guidant has agreed to acquire BioStent, a start-up medical device company specializing in bioabsorbable vascular stents. It is buying 51% of the company now for $10mm, and in early 2004 plans to buy the remaining 49% for an additional $6mm, based on BioStent's achievement of certain requirements.
Deal Industry
-
Medical Devices
- Biomaterials
- Implantable Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Partial Acquisition
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Guidant buys BioStent
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice